17 results on '"Versteeg, H"'
Search Results
2. OC 46.1 Absolute Quantitative Proteomics for Occult Cancer Screening in Patient with Unprovoked Venous Thromboembolism: Results from the Prospective PLATO-VTE Study
- Author
-
Guman, N., primary, Kraaijpoel, N., additional, Mulder, F., additional, Carrier, M., additional, Jara-Palomares, L., additional, Di Nisio, M., additional, Ageno, W., additional, Beyer-Westendorf, J., additional, Klok, E., additional, Vanassche, T., additional, Otten, H., additional, Cosmi, B., additional, Kamphuisen, P., additional, Sánchez-López, V., additional, Best, M., additional, Bossuyt, P., additional, Versteeg, H., additional, van Vlijmen, B., additional, van Es, N., additional, and Mohammed, Y., additional
- Published
- 2023
- Full Text
- View/download PDF
3. OC 46.2 Plasma Protein Signature by Targeted Mass Spectrometry Allows Prediction of Venous Thromboembolism in Colorectal Cancer Patients with 90% Sensitivity
- Author
-
Buijs, J., primary, van Es, N., additional, Anijs, R., additional, Bosch, F., additional, van Vlijmen, B., additional, Mulder, F., additional, Versteeg, H., additional, and Mohammed, Y., additional
- Published
- 2023
- Full Text
- View/download PDF
4. Lupus anticoagulant associates with thrombosis in patients with COVID-19 admitted to intensive care units
- Author
-
Noordermeer, Tessa, Schutgens, Roger E. G., Visser, Chantal, Rademaker, Emma, de Maat, Moniek P. M., Jansen, A. J. Gerard, Limper, Maarten, Cremer, Olaf L., Kruip, Marieke J. H. A., Endeman, Henrik, Maas, Coen, de Laat, Bas, Urbanus, Rolf T., van de Beek, D., Brouwer, M. C., de Bruin, S., Coppens, M., van Es, N., van Haaps, T. F., Juffermans, N. P., Muller, M. C. A., Vlaar, A. P. J., Hertogh, C. M. P. M., Heunks, L. M. A., Hugtenburg, J. G., van Kooten, J., Nossent, E. J., Smulders, Y., Tuinman, P. R., Noordegraaf, A. Vonk, Grootenboers, M. J. J. H., van Guldener, C., Kant, M., Lansbergen, A., Faber, J., Hajer, G., Stemerdink, A., van den Akker, J., Bierings, R., Endeman, H., Goeijenbier, M., Hunfeld, N. G. M., van Gorp, E. C. M., Gommers, D. A. M. P. J., Koopmans, M. P. G., Kruip, M. J. H. A., Kuiken, T., Langerak, T., Leebeek, Lauw, M. N., de Maat, M. P. M., Noack, D., Paats, M. S., Raadsen, M. P., Rockx, B., Rokx, C., Schurink, C. A. M., Tong-Minh, K., van den Toorn, L., den Uil, C. A., Visser, C., Boutkourt, F., Roest, T., Douma, R. A., de Haan, L. R., ten Wolde, M., Bemelmans, R. H. H., Festen, B., Stads, S., de Jager, C. P. C., Simons, K. S., Antoni, M. L., Bos, M. H., Burggraaf, J. L. I., Cannegieter, S. C., Eikenboom, H. C. J., den Exter, P. L., Geelhoed, J. J. M., Huisman, M. V., de Jonge, E., Kaptein, F. H. J., Klok, F. A., Kroft, L. J. M., Lijfering, W. M., Nab, L., Ninaber, M. K., Putter, H., Ramai, S. R. S., da Rocha Rondon, A. M., Roukens, A. H. E., Stals, M. A. M., Versteeg, H. H., Vliegen, H. W., van Vlijmen, B. J. M., van de Berg, T., Bruggemann, R., van Bussel, B. C. T., ten Cate, H., ten Cate-Hoek, A., Hackeng, T. M., Henskens, ir. Y., Hulshof, A., Mulder, M., Olie, R. H., Schurgers, L., Spaetgens, B., Spronk, H., Spruit, M. A., Winckers, K., Nieuwenhuizen, L., Franken, B., Schrover, I. M., de Waal, E. G. M., Beishuizen, A., Cornet, A., Krabbe, J., Kramers, K., Leentjens, J., de Mast, Q., Middeldorp, S., Brouwer, R. E., Ellerbroek, J. L. J., Tijmensen, J., Hovens, M. M. C., Oostdijk, E. A. N., Westerhof, B. D., Faber, L. M., van den Biggelaar, M., Meijers, J. C. M., Voorberg, J., Kevenaar, M. E., Soei, Y. L., Wils, E. J., Croles, F. N., de Laat, B., Kamphuisen, P. W., Vink, R., Lisman, T., Meijer, K., van Tichelaar, Y. I. G., Cremer, O. L., Geersing, G., Kaasjager, H. A. H., Kusadasi, N., Huisman, A., Maas, C., Nijkeuter, M., Schutgens, R. E. G., Creveldkliniek, Van, Urbanus, R. T., Westerink, J., Faber, H. J., Koster, S. C. E., van Montfort, P., van Twist, D. J. L., RS: Carim - B01 Blood proteins & engineering, Biochemie, Hematology, Intensive Care, Neurology, ANS - Neuroinfection & -inflammation, Intensive Care Medicine, ACS - Pulmonary hypertension & thrombosis, AII - Inflammatory diseases, Vascular Medicine, ACS - Amsterdam Cardiovascular Sciences, Graduate School, ACS - Microcirculation, Medical Microbiology and Infection Prevention, ARD - Amsterdam Reproduction and Development, Experimental Vascular Medicine, Landsteiner Laboratory, ACS - Atherosclerosis & ischemic syndromes, Elderly care medicine, APH - Aging & Later Life, Clinical pharmacology and pharmacy, APH - Health Behaviors & Chronic Diseases, Pulmonary medicine, Internal medicine, ACS - Diabetes & metabolism, Intensive care medicine, General practice, and Amsterdam Gastroenterology Endocrinology Metabolism
- Subjects
lnfectious Diseases and Global Health Radboud Institute for Health Sciences [Radboudumc 4] ,lupus anticoagulant ,risk factor ,critically ill ,Vascular damage Radboud Institute for Health Sciences [Radboudumc 16] ,lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4] ,COVID-19 ,Hematology ,thrombosis ,Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18] - Abstract
Contains fulltext : 286889.pdf (Publisher’s version ) (Open Access) BACKGROUND: Thrombosis is a frequent and severe complication in patients with coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU). Lupus anticoagulant (LA) is a strong acquired risk factor for thrombosis in various diseases and is frequently observed in patients with COVID-19. Whether LA is associated with thrombosis in patients with severe COVID-19 is currently unclear. OBJECTIVE: To investigate if LA is associated with thrombosis in critically ill patients with COVID-19. PATIENTS/METHODS: The presence of LA and other antiphospholipid antibodies was assessed in patients with COVID-19 admitted to the ICU. LA was determined with dilute Russell's viper venom time (dRVVT) and LA-sensitive activated partial thromboplastin time (aPTT) reagents. RESULTS: Of 169 patients with COVID-19, 116 (69%) tested positive for at least one antiphospholipid antibody upon admission to the ICU. Forty (24%) patients tested positive for LA; of whom 29 (17%) tested positive with a dRVVT, 19 (11%) tested positive with an LA-sensitive aPTT, and 8 (5%) tested positive on both tests. Fifty-eight (34%) patients developed thrombosis after ICU admission. The odds ratio (OR) for thrombosis in patients with LA based on a dRVVT was 2.5 (95% confidence interval [CI], 1.1-5.7), which increased to 4.5 (95% CI, 1.4-14.3) in patients at or below the median age in this study (64 years). LA positivity based on a dRVVT or LA-sensitive aPTT was only associated with thrombosis in patients aged less than 65 years (OR, 3.8; 95% CI, 1.3-11.4) and disappeared after adjustment for C-reactive protein. CONCLUSION: Lupus anticoagulant on admission is strongly associated with thrombosis in critically ill patients with COVID-19, especially in patients aged less than 65 years.
- Published
- 2022
- Full Text
- View/download PDF
5. Unlocking further understanding of the atomization mechanism of a pressurized metered dose inhaler
- Author
-
Myatt, B. J., primary, Versteeg, H. K., additional, Hargrave, G. K., additional, Long, E. J., additional, Gavtash, B., additional, Lewis, D. A., additional, Church, T., additional, and Brambilla, G., additional
- Published
- 2022
- Full Text
- View/download PDF
6. Using group model building to capture the complex dynamics of scaling up district-level surgery in Arusha region, Tanzania
- Author
-
Broekhuizen-Versteeg, H., Lansu, M.E.M., Gajewski, J., Pittalis, C., Ifeanyichi, M.I., Juma, A., Marealle, P., Kataika, E., Rouwette, E.A.J.A., Brugha, R., Bijlmakers, L.A., Broekhuizen-Versteeg, H., Lansu, M.E.M., Gajewski, J., Pittalis, C., Ifeanyichi, M.I., Juma, A., Marealle, P., Kataika, E., Rouwette, E.A.J.A., Brugha, R., and Bijlmakers, L.A.
- Abstract
13 december 2020, Contains fulltext : 235921.pdf (Publisher’s version ) (Open Access)
- Published
- 2022
7. Mosquito borne diseases in the Netherlands: a game theory perspective
- Author
-
Broekhuizen-Versteeg, H., Bekius, F.A., Broekhuizen-Versteeg, H., and Bekius, F.A.
- Abstract
Research seminar Health and Society group, 22 december 2022, Wageningen University and Research, Item does not contain fulltext
- Published
- 2022
8. Unlocking further understanding of the atomisation mechanism of a pressurized metered dose inhaler
- Author
-
Myatt, B. J., Versteeg, H. K., Hargrave, G. K., Long, E. J., Gavtash, B., Lewis, D. A., Church, T., and Brambilla, G.
- Abstract
Pressurised metered dose inhalers (pMDI) are one of the most common devices to deliver therapeutic treatment to patients with asthma or COPD. The atomisation mechanism responsible for droplet production is poorly understood because of the short length and timescales involved, making experimental investigations to characterise fluid flow structures and spray formation processes difficult. This article reports the findings of new high-speed and high-resolution imaging and temperature measurements seeking to improve the fundamental understanding of the atomisation mechanism of the pMDI. An annular flow regime of gaseous core in liquid annulus was observed in the orifice. Shock diamonds within the flow, viewed via Schlieren imaging, confirmed experimentally for the first time the choked nature of the orifice exit flow. Propellant formulation flow in the orifice was found to be superheated to a degree that significant flashing and evaporation at the orifice exit is likely to take place. This information points to a hybrid mechanism of predominantly aerodynamic atomisation with significant liquid flashing upon exit from the orifice producing a near instantaneous formation of respirable droplets. Large irrespirable droplets are produced by two mechanisms; breakup of liquid slugs ejected from the orifice, due to unsteady transient fluid structures in the actuator sump and stripping of ligaments from a liquid pool around the orifice exit, which subsequently break up into large droplets in the periphery of the plume. This new understanding will aid development of next generation, high efficiency pMDIs, particularly those employing low global warming potential propellants such as HFA152a or HFO1234ze(E).
- Published
- 2022
- Full Text
- View/download PDF
9. 1328: Feasibility of a nurse practitioner coordinated multidis-ciplinary rapid access clinic for patients with chronic dyspnoea, a pilot-study.
- Author
-
Wetering, H. Van De, Versteeg, H., Hof, A.W.J. Van'T, and Berg, J.W.K. Van Den
- Subjects
- *
DIAGNOSIS of dyspnea , *HEALTH services accessibility , *CHRONIC diseases , *CONFERENCES & conventions , *DYSPNEA , *MEDICAL emergencies , *HOSPITAL nursing staff , *HEALTH care teams - Abstract
The article discusses the feasibility of a rapid access dyspnea outpatient clinic coordinated by a Nurse Practitioner to diagnose the etiology of chronic dyspnea, irrespective of cardiac or pulmonary origin, within one day.
- Published
- 2022
- Full Text
- View/download PDF
10. Effect of excitation sequence of myocardial contraction on the mechanical response of the left ventricle.
- Author
-
Troulliotis G, Duncan A, Xu XY, Gandaglia A, Naso F, Versteeg H, Mirsadraee S, and Korossis S
- Subjects
- Biomechanical Phenomena, Humans, Models, Cardiovascular, Time Factors, Myocardial Contraction, Heart Ventricles, Mechanical Phenomena
- Abstract
In the past two decades there has been rapid development in the field of computational cardiac models. These have included either (i) mechanical models that assumed simultaneous myocardial activation, or (ii) electromechanical models that assumed time-varying myocardial activation. The influence of these modelling assumptions of myocardial activation on clinically relevant metrics, like myocardial strain, commonly used for validation of cardiac models has yet to be systematically examined, leading to uncertainty over their influence on the predictions of these models. This study examined the effects of simultaneous (mechanical), uniform endocardial, 3-patch endocardial (simulating the fascicles of the His-Purkinje system) and 1-patch endocardial (simulating the atrioventricular node) excitation sequences on the mechanical response of a synthetic human left ventricular model. The influence of the duration of the activation and time-to-peak contraction was also investigated. The electromechanical and mechanical models produced different strain distributions in early systole. However, these differences decayed as systole progressed. Using the same activation duration (74 ms) the average peak-systolic circumferential strain difference between the models was 0.65±0.37 %. A slightly prolonged activation duration (134 ms) resulted in no substantial difference increase (0.76±0.47 %). Differences up to 3.5 % were observed for prolonged activation durations (200 ms). Endocardial excitation produced non-physiological cumulative activation time distributions compared to the other models. Septal 1-patch excitation resulted in early systolic strain response that resembled pathological left bundle branch block. Decreased time-to-peak contraction exaggerated the effects of electrophysiology. The study found that excitation sequence minimally affects strain distributions at peak systole for physiological and even slightly pathological activation durations. However, electromechanical models with (patho)physiologically informed activation sequences are important for the accurate prediction of early systolic and pathological late systolic responses., Competing Interests: Declaration of competing interest None declared., (Copyright © 2024. Published by Elsevier Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
11. Economic evaluation of remote monitoring of patients with an implantable cardiac defibrillator (REMOTE-CIED study).
- Author
-
de Graaf G, Timmermans I, Meine M, Alings M, Pedersen SS, Mabo P, Zitron E, Redekop K, and Versteeg H
- Subjects
- Humans, Male, Female, Germany, Aged, Middle Aged, Heart Failure therapy, Heart Failure economics, Netherlands, France, Health Care Costs statistics & numerical data, Telemedicine economics, Length of Stay statistics & numerical data, Length of Stay economics, Hospitalization economics, Hospitalization statistics & numerical data, Defibrillators, Implantable economics, Quality-Adjusted Life Years, Cost-Benefit Analysis
- Abstract
Introduction: Remote patient monitoring (RPM) of heart failure patients has the potential to reduce healthcare resource use and costs, but current evidence has been inconclusive. This study aims assess the impact of RPM of heart failure patients with an implantable cardioverter defibrillator on medical resource use, direct medical costs, quality-adjusted life years (QALYs), and travel time of patients, and to estimate its commercial headroom in the Netherlands and Germany., Methods: Data from the REMOTE-CIED randomized controlled trial were used to calculate differences in length of hospital stay, outpatient clinic visits, telephone consults, emergency room visits, and travel time between patients on in-clinic follow-up and RPM in the Netherlands, Germany, and France. Incremental cardiac-related healthcare costs and QALYs were calculated and used to calculate the commercial headroom of RPM in the Netherlands and Germany. The impact of imputation, parameter, and case-mix uncertainty on these outcomes was explored using probabilistic analysis., Results: Length of hospitalization, number of unscheduled admissions, and number of outpatient visits were lower in the remote monitoring group in all three countries. Number of hospital admissions was higher, and number of calls was lower in the Netherlands and Germany but not in France. Costs were lower in both the Netherlands (-€1041, 95% confidence interval (CI): -€3308, €1005) and Germany (-€2865, 95% CI: -€7619, €1105), while incremental effectiveness differed: -0.003 (95% CI: -0.114, 0.107) QALY in the Netherlands and +0.086 (95% CI: -0.083, 0.256) in Germany. Commercial headroom was estimated at €881 (95% CI: -€5430, €7208) in the Netherlands and €5005 (95% CI: -€1339, €11,960) in Germany., Discussion: RPM was found to result in reduced medical resource use and travel time. Whether it is cost saving or cost effective strongly depends on the costs of remote monitoring., Trial Registration Number and Trial Register: ClinicalTrials.gov: NCT01691586., Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
12. Reply to 'letter-to-the-editor'.
- Author
-
Buijs JT, Najidh S, and Versteeg HH
- Abstract
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
- Published
- 2024
- Full Text
- View/download PDF
13. Venous and arterial thromboembolism after colorectal cancer in the Netherlands: Incidence, predictors, and prognosis.
- Author
-
Anijs RJS, Chen Q, van der Hulle T, Versteeg HH, Klok FA, Lijfering WM, and Cannegieter SC
- Subjects
- Humans, Incidence, Cohort Studies, Netherlands epidemiology, Prognosis, Risk Factors, Venous Thromboembolism epidemiology, Venous Thromboembolism etiology, Colorectal Neoplasms complications, Colorectal Neoplasms epidemiology
- Abstract
Background: Colorectal cancer (CRC) is the third most prevalent cancer type. CRC-patients are at increased risk of venous and arterial thromboembolism (TE), but the magnitude of the risks, their predictors and consequences are not exactly known., Objectives: We aimed to determine incidence, predictors and prognosis of TE after incident CRC in a large, unselected population., Methods: Using data from Statistics Netherlands and the Netherlands Comprehensive Cancer Organization, all incident CRC-patients were identified between 2013 and 2018 plus a sample of 1:2 age- and sex-matched control subjects. Incidence rates and cumulative incidences for TE were estimated. Predictor variables for TE were explored by univariable Cox regression. The association between TE and all-cause mortality was evaluated by multivariable time-dependent Cox regression., Results: 68,238 incident CRC-patients were matched to 136,476 controls. CRC-patients had a 1-year cumulative venous TE (VTE) incidence of 1.93 % (95%CI 1.83-2.04), versus 0.24 % (95%CI 0.21-0.27) in controls (HR 8.85; 95%CI 7.83-9.99). For arterial TE (ATE), this was 2.74 % (95%CI 2.62-2.87) in CRC versus 1.88 % (95%CI 1.81-1.95) in controls (HR 1.57; 95%CI 1.47-1.66). Cancer stage, surgery, chemotherapy and asthma were predictors for VTE, whereas age, prior ATE and Parkinson's disease were predictors for ATE. CRC patients with TE had an increased risk of all-cause mortality (VTE HR; 3.68 (95%CI 3.30-4.10, ATE HR; 3.05 (95%CI 2.75-3.39)) compared with CRC-patients without TE., Conclusions: This Dutch nationwide cohort study adds detailed knowledge on the risk of VTE and ATE, their predictors and prognosis in CRC-patients. These findings may drive TE prophylactic management decisions., Competing Interests: Declaration of competing interest Q. Chen is supported by the Chinese Government Scholarship (No. 201906380148) for his PhD at the Leiden University Medical Center. Prof. Dr. Klok has received research support from Bayer, Bristol-Myers Squibb, Actelion, Boston Scientific, Leo Pharma, The Netherlands Organization for Health Research and Development, The Dutch Thrombosis Association, The Dutch Heart Foundation and the Horizon Europe program, all outside this work and paid to his institution., (Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
14. The GENESIS-UV study on ultraviolet radiation exposure levels in 250 occupations to foster epidemiological and legislative efforts to combat nonmelanoma skin cancer.
- Author
-
Wittlich M, Westerhausen S, Strehl B, Versteeg H, and Stöppelmann W
- Subjects
- Humans, Ultraviolet Rays, Occupations, Skin radiation effects, Skin Neoplasms prevention & control, Occupational Diseases, Occupational Exposure
- Abstract
Background: Several hundred million of the 3 billion formally employed people worldwide are at risk from high levels of solar ultraviolet radiation (UVR). Chronic light damage to the skin can lead to nonmelanoma skin cancer (NMSC), especially when irradiation is too high and is acquired for decades. However, data with uniform metrics, high resolution over time and in-depth occupational profiles are not available., Objectives: To build a worldwide usable matrix of UVR exposure in occupations and to show use cases for the data., Methods: One thousand test persons were recruited to wear electronic data logger dosimeters during their working time for 7 months each. The measurements yielded 3.7 billion data points for around 48 000 days with high-quality data capture covering more than 250 occupations and 650 activities. Scientific evaluation of the data included daily and half-hourly means, geographical transfer calculations to the world, threshold exceedance quotas, transcriptome effects, and occupational disease estimates., Results: A compendium for global use is presented. In-depth analyses and the resulting implications for research have been elaborated to directly link exposure data to effects in the human body. Interestingly, the annual irradiances of the different occupations span a wide range of values: from about 650 to 50 standard erythemal doses, with different distributions over the months. Detailed exposure data per occupation were derived, and the risk on an occupational or activity basis assuming different exposure level quotas was quantified. This showed that, for example, in temperate latitudes, all activities with a duration of > 2 h outdoors are associated with increased NMSC risk., Conclusions: We offer our work to enable sound studies on the nature of ultraviolet-induced skin cancer, dose-response relationships, intermittency of skin exposure, and derivation of limit values. Sociological studies on prevention are now possible. Practitioners may use the findings for their daily work with employees., Competing Interests: Conflicts of interest The authors declare they have no conflicts of interest., (© The Author(s) 2022. Published by Oxford University Press on behalf of British Association of Dermatologists.)
- Published
- 2023
- Full Text
- View/download PDF
15. Assessment of breast cancer progression and metastasis during a hypercoagulable state induced by silencing of antithrombin in a xenograft mouse model.
- Author
-
Buijs JT, Ünlü B, Laghmani EH, Heestermans M, van Vlijmen BJM, and Versteeg HH
- Subjects
- Humans, Female, Animals, Mice, Antithrombins, Disease Models, Animal, Heterografts, Mice, SCID, Anticoagulants, Antithrombin III genetics, RNA, Small Interfering, Thrombophilia genetics, Breast Neoplasms complications, Breast Neoplasms genetics
- Abstract
Local coagulation activation has been shown to impact both primary tumor growth and metastasis in mice. It is well known that components of the blood clotting cascade such as tissue factor and thrombin play a role in tumor progression by activating cellular receptors and local formation of fibrin. However, whether venous thromboembolism (VTE) or a hypercoagulable state has a direct impact on cancer progression is unknown. Here we have combined an orthotopic murine breast cancer model, using female Nod-SCID mice, with siRNA-mediated silencing of antithrombin (siAT) leading to the induction of a systemic hypercoagulable state. We show that, compared to control siRNA-treated (not experiencing a hypercoagulable state) tumor-bearing mice, siAT treated tumor-bearing mice do not show enhanced tumor growth nor enhanced metastasis. We conclude that, in this murine model for hypercoagulability, induction of a hypercoagulable state does not contribute to breast cancer progression., Competing Interests: Declaration of competing interest The authors have nothing to disclose with regard to commercial support., (Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
16. UVR Exposure and Prevention of Street Construction Workers in Colombia and Germany.
- Author
-
Calvache Ruales MF, Westerhausen S, Zapata Gallo HA, Strehl B, Naza Guzman SD, Versteeg H, Stöppelmann W, and Wittlich M
- Subjects
- Colombia, Germany, Humans, Tropical Climate, Ultraviolet Rays adverse effects, Construction Industry, Occupational Exposure analysis, Occupational Exposure prevention & control, Skin Neoplasms prevention & control
- Abstract
(1) Solar ultraviolet radiation (UVR) poses a major risk factor for developing skin cancer after years of chronic exposure. The irradiation is strongly dependent upon the activity or occupation carried out, but also on the climate conditions at the workplace. Knowledge of both has been tested within the occupational group of road construction workers in Colombia and Germany. (2) The GENESIS-UV measurement system has been used at both locations for consistency. A number of workers in both countries wore an electronic data logging dosimeter for several months to deliver detailed information on UVR exposure. (3) It was found that in a tropical climate, UVR exposure remains constant throughout the year, while in a temperate climate seasonal effects are visible, superimposed by behavioural aspects e.g., in springtime. The daily distribution of the radiation shows a distinct dip, especially in the Colombian data. Derived data show the high fraction of working days exceeding a threshold set by the skin type. (4) Road construction work involves high UVR exposure. In both countries, preventive measures are required to reduce the personal exposure to a minimum. Exceedance of the minimal erythema dose (MED) suggests a possible enhancing effect, especially in fair skinned people. Intercomparison of UVR exposure at workplaces is possible between countries and climate zones, emphasizing efforts for global action against skin cancer.
- Published
- 2022
- Full Text
- View/download PDF
17. Effect of remote monitoring on clinical outcomes in European heart failure patients with an implantable cardioverter-defibrillator: secondary results of the REMOTE-CIED randomized trial.
- Author
-
Chiu CSL, Timmermans I, Versteeg H, Zitron E, Mabo P, Pedersen SS, and Meine M
- Subjects
- Humans, Pandemics, SARS-CoV-2, COVID-19, Defibrillators, Implantable, Heart Failure diagnosis, Heart Failure therapy
- Abstract
Aims: Remote patient monitoring (RPM) systems offer a promising alternative to conventional In-Clinic check-ups, hereby reducing unnecessary clinic visits. Especially with the rise of the COVID-19 pandemic, this reduction is of paramount importance. Regarding the association between RPM and clinical outcomes, findings of previous studies have been inconsistent. The aim of this study is to elucidate the effect of partly substituting In-Clinic visits by RPM on clinical outcomes in implantable cardioverter-defibrillator (ICD) patients., Methods and Results: The study included 595 heart failure patients (LVEF ≤35%; NYHA Class II/III) implanted with an ICD compatible with the Boston Scientific LATITUDE™ system. Participants were randomized to RPM plus an annual In-Clinic visit or 3-6 months In-Clinic check-ups alone. The investigated endpoints after 2 years of follow-up included a composite of all-cause mortality and cardiac hospitalization, mortality and cardiac hospitalization as independent endpoints and ICD therapy. The incidence of mortality and hospitalization did not differ significantly as independent, nor as composite endpoint between the RPM and In-Clinic group (all Ps <0.05). The results were similar regarding ICD therapy, except for appropriate ICD therapy (odds ratio 0.50; 95% confidence interval 0.26-0.98; P = 0.04). Exploratory subgroup analyses indicated that the effect of RPM differs between patients with specific characteristics, i.e. ≥60 years and permanent atrial fibrillation (all Ps < 0.05)., Conclusion: RPM is non-inferior to conventional In-Clinic visits regarding clinical outcomes. Routine In-Clinic follow-up may partly be substituted by RPM without jeopardizing safety and efficiency, and thus reducing unnecessary In-Clinic visits., Clinicaltrials.gov Identifier: NCT01691586., (© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.